Hande Erman, Engin Beydogan, Seher Irem Cetin, & Banu Boyuk. (2020). Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Hindawi Limited.
Chicago Style (17th ed.) CitationHande Erman, Engin Beydogan, Seher Irem Cetin, and Banu Boyuk. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Hindawi Limited, 2020.
MLA (9th ed.) CitationHande Erman, et al. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome. Hindawi Limited, 2020.
Warning: These citations may not always be 100% accurate.